ABBV vs JNJ — AbbVie Inc. vs Johnson & Johnson Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
QuantSoar AI Verdict
ABBV is the better value pick
ABBV: $263.04 · Margin of Safety -29.8%|JNJ: $266.32 · Margin of Safety -57.6%
Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
Loading performance data...
Fundamentals & Valuation Deep Dive
Side-by-side financial metrics and valuation models.
ABBVMetricJNJ
$263.04Current Price$266.32
86.72Fair Value103.68
-67.0%Margin of Safety-61.1%
74.5P/E Ratio30.9
7.2P/S Ratio6.6
78.3P/B Ratio7.5
0.28Beta0.23
$464.8BMarket Cap$641.8B
0.03%Dividend Yield0.02%
9.8%Profit Margin21.5%
40.0%Operating Margin29.2%
—ROE25.7%
$61.2BRevenue$94.2B
16.2Forward P/E21.5
0.0Debt / Equity57.7
$278.61Analyst Target$277.91
financialProfile
AbbVie Inc.
Current Price$263.04
Fair Value$86.72
Margin of Safety-67.0%
P/E Ratio74.5
P/S Ratio7.2
P/B Ratio-78.3
Beta0.3
Dividend Yield0.03%
Profit Margin9.8%
Operating Margin40.0%
ROE—
Revenue$61.2B
Forward P/E16.2
Debt / Equity—
Analyst Target$278.61
Market Cap$464.8B
financialProfile
Johnson & Johnson
Current Price$266.32
Fair Value$103.68
Margin of Safety-61.1%
P/E Ratio30.9
P/S Ratio6.6
P/B Ratio7.5
Beta0.2
Dividend Yield0.02%
Profit Margin21.5%
Operating Margin29.2%
ROE25.7%
Revenue$94.2B
Forward P/E21.5
Debt / Equity57.7
Analyst Target$277.91
Market Cap$641.8B
Smart Investment Matcher
Input your budget and horizon. We simulate DCA backtests and recommend the best fit.
Loading smart matcher...
Final Verdict & Actionable Takeaways
Our quantitative verdict
ABBV offers better risk-adjusted value
Based on margin of safety (ABBV wins) and beta safety (JNJ wins).
Related Stock Comparisons
Explore other popular side-by-side matchups and sector peers.